Multicoin Capital has made Hyperliquid's HYPE token the largest position in its $2.7 billion hedge fund, emphasizing its continued focus on cryptocurrency investments despite a growing trend among rivals to invest in AI and robotics. The firm accumulated HYPE through public-market purchases and values Hyperliquid's potential to evolve into a broad financial exchange, projecting a possible valuation scenario of over $319 per token. While other crypto funds diversify into AI, Multicoin remains confident in its digital asset strategy, maintaining selective AI exposure only where it intersects with blockchain infrastructure. This move highlights Multicoin's commitment to crypto amid shifting investment trends and raises questions about portfolio concentration due to the size of the HYPE holding.
Multicoin Capital's largest holding in Hyperliquid's HYPE token is notable amid a $2.7 billion hedge fund portfolio. For readers following the cryptocurrency sector, here is Pluang's market snapshot as of Oct 20, 2026 02:41 WIB: out of 50 major cryptocurrencies, 43 rose and 6 fell today. Notable movers include XTZ (Tezos) at Rp5.402 with 0% Sell / 100% Buy order activity and a typical hold time of 100 days, SNX (Synthetix) at Rp3.868 with 99% Sell / 1% Buy, and LTC (Litecoin) at Rp1.077.231 with 73% Sell / 27% Buy.
The Canadian Investment Regulatory Organization (CIRO) has temporarily halted trading of all shares of Bighorn Metals Corp. (symbol HRNY) as of 1:10 PM ET on October 19, 2026. The halt is pending further information from the company and aims to maint...
The HCA Healthcare Foundation awarded $25,000 to Waypoint (formerly Virginia Home for Boys and Girls) to expand its network of adults trained to support youth mental wellness across Virginia. This funding supports Waypoint's Therapeutic Resources tea...
Angle Advisors has appointed Chris Gessner as a Managing Director, bringing over 20 years of experience in corporate finance, including lending, private equity, and M&A advisory. Gessner's background spans various transaction types and industries suc...
The FDA has approved Jemperli (dostarlimab) as the first immunotherapy for adults with stage II and III MSI-H/dMMR locally advanced rectal cancer. This approval is based on the AZUR-1 trial showing 68% of patients achieved complete clinical response ...
Ethereum-based crypto Pepeto is in its final presale stages ahead of a Binance listing, with rapid investor interest driving record presale speed. Pepeto addresses issues Cardano aimed to fix, such as high fees and network congestion, offering zero-f...
